540204 EIKO

Eiko Lifesciences Share Price

₹62.48 -0.09 (-0.14%)

30 Dec, 2024 01:30

SIP TrendupStart SIP in EIKO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 2.54%
  • Over 3 Month + 7.72%
  • Over 6 Month + 26.61%
  • Over 1 Year -4.63%
SIP Lightning

Smart Investing Starts Here Start SIP with Eiko Lifesciences for Steady Growth!

Invest Now

Eiko Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Eiko Lifesciences Financials

Eiko Lifesciences Technicals

EMA & SMA

Current Price
₹62.48
-0.09 (-0.14%)
pointer
  • stock-down_img
  • Bullish Moving Average 9
  • stock-up_img
  • Bearish Moving Average 7
  • 20 Day
  • ₹62.83
  • 50 Day
  • ₹62.14
  • 100 Day
  • ₹61.12
  • 200 Day
  • ₹60.00

Resistance and Support

62.32 Pivot Speed
  • R3 66.18
  • R2 65.09
  • R1 63.41
  • S1 60.64
  • S2 59.55
  • S3 57.87

What's your outlook on Eiko Lifesciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Eiko Lifesciences has an operating revenue of Rs. 33.50 Cr. on a trailing 12-month basis. An annual revenue growth of 47% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -11% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 83 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Eiko Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-25 Rights issue of Equity Shares
2024-10-19 Quarterly Results
2024-08-13 Quarterly Results
2024-05-13 Audited Results
2024-02-08 Quarterly Results

Eiko Lifesciences F&O

Eiko Lifesciences Shareholding Pattern

24.4%
49.05%
26.55%

About Eiko Lifesciences

  • NSE Symbol
  • EIKO
  • BSE Symbol
  • 540204
  • ISIN
  • INE666Q01016

Similar Stocks to Eiko Lifesciences

Eiko Lifesciences FAQs

Eiko Lifesciences share price is ₹62 As on 30 December, 2024 | 01:16

The Market Cap of Eiko Lifesciences is ₹62.4 Cr As on 30 December, 2024 | 01:16

The P/E ratio of Eiko Lifesciences is 56.4 As on 30 December, 2024 | 01:16

The PB ratio of Eiko Lifesciences is 1.1 As on 30 December, 2024 | 01:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23